Viviane Monges has served as a member of ADC Therapeutics' board of directors since June 2021 and has more than 30 years of executive-level financial leadership experience with global corporations, predominantly in the pharmaceutical industry. From 2015 to 2017 she served as Chief Financial Officer of the Business Excellence Division at Nestle, and previously as Group CFO at Galderma; EMEA CFO and then Global CFO of the OTC Division at Novartis; and CFO of the Europe Region and of the Global Pharma Business unit at Wyeth Pharmaceuticals/Pfizer. She also serves on the boards of bioMerieux and Pharvaris, and previously served on the boards of UCB, EUROAPI, Idorsia and DBV Technologies. She holds a B.A. and an M.B.A. in finance and public administration from the Ecole Superieure de Commerce de Paris.